Date published: 2025-10-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

2′,2′-Difluoro-2′-deoxyuridine (CAS 114248-23-6)

5.0(1)
Write a reviewAsk a question

See product citations (2)

Alternate Names:
2′-Deoxy-2′,2′-difluorouridine; 2,2-Difluorodeoxyuridine
Application:
2′,2′-Difluoro-2′-deoxyuridine is a metabolite product of gemcitabine
CAS Number:
114248-23-6
Purity:
97%
Molecular Weight:
264.18
Molecular Formula:
C9H10F2N2O5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

A metabolite product of Gemcitabine.


2′,2′-Difluoro-2′-deoxyuridine (CAS 114248-23-6) References

  1. Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine.  |  Beumer, JH., et al. 2008. Clin Cancer Res. 14: 3529-35. PMID: 18519786
  2. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.  |  Abbruzzese, JL., et al. 1991. J Clin Oncol. 9: 491-8. PMID: 1999720
  3. Modulatory activity of 2',2'-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides.  |  Gandhi, V. and Plunkett, W. 1990. Cancer Res. 50: 3675-80. PMID: 2340517
  4. Inhibition of thymidylate synthase by 2',2'-difluoro-2'-deoxycytidine (Gemcitabine) and its metabolite 2',2'-difluoro-2'-deoxyuridine.  |  Honeywell, RJ., et al. 2015. Int J Biochem Cell Biol. 60: 73-81. PMID: 25562513
  5. Preanalytical Stability of Gemcitabine and its Metabolite 2', 2'-Difluoro-2'-Deoxyuridine in Whole Blood-Assessed by Liquid Chromatography Tandem Mass Spectrometry.  |  Bjånes, T., et al. 2015. J Pharm Sci. 104: 4427-4432. PMID: 26372902
  6. LC-MS/MS method for quantitation of gemcitabine and its metabolite 2',2'-difluoro-2'-deoxyuridine in mouse plasma and brain tissue: Application to a preclinical pharmacokinetic study.  |  Zhong, B., et al. 2021. J Pharm Biomed Anal. 198: 114025. PMID: 33744463
  7. Cytosine arabinoside influx and nucleoside transport sites in acute leukemia.  |  Wiley, JS., et al. 1982. J Clin Invest. 69: 479-89. PMID: 6948829
  8. Determination of the antimetabolite Gemcitabine (2',2'-difluoro-2'-deoxycytidine) and of 2',2'-difluoro-2'-deoxyuridine by 19F nuclear magnetic resonance spectroscopy.  |  Edzes, HT., et al. 1993. Anal Biochem. 214: 25-30. PMID: 8250231
  9. Characterization of a novel Na+-dependent, guanosine-specific, nitrobenzylthioinosine-sensitive transporter in acute promyelocytic leukemia cells.  |  Flanagan, SA. and Meckling-Gill, KA. 1997. J Biol Chem. 272: 18026-32. PMID: 9218431
  10. Development and validation of an ion pair HPLC method for gemcitabine and 2′, 2′-difluoro-2′-deoxyuridine determination  |  Losa, R., Sierra, M. I., Guardado, C., Fernandez, A., Gión, M. O., Blanco, D., & Buesa, J. M. 2005. Analytica chimica acta. 528(2): 255-260.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

2′,2′-Difluoro-2′-deoxyuridine, 5 mg

sc-220827
5 mg
$430.00